Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Outcome Measures in Psoriatic Arthritis
1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK; Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, USA.
Recent advances in psoriatic arthritis (PsA) research include new ways to measure disease activity and impact. This review covers key outcome measures for assessing function, quality of life, and fatigue in PsA patients.
Area of Science:
- Rheumatology
- Clinical Measurement
- Patient-Reported Outcomes
Background:
- Psoriatic arthritis (PsA) management requires robust outcome measures.
- Significant progress has been made in developing and validating PsA outcome measures over the past decade.
Purpose of the Study:
- To review current outcome measures for disease activity in PsA.
- To summarize patient-reported outcome measures (PROMs) including function, quality of life, and fatigue.
- To discuss new composite measures and future directions in PsA outcome research.
Main Methods:
- Literature review of outcome measure research in psoriatic arthritis.
- Analysis of individual domain measures and composite scores.
- Synthesis of findings on disease activity, patient impact, and future research needs.
Main Results:
- Key outcome measures for disease activity in PsA domains are identified.
- Important patient-reported outcome measures, including the Psoriatic Arthritis Impact of Disease score, are highlighted.
- New composite measures, response criteria, and disease activity cutoffs are summarized.
Conclusions:
- The field of outcome measurement in PsA has advanced significantly.
- Comprehensive assessment requires evaluating disease activity, patient function, quality of life, and disease impact.
- Future research should address remaining challenges in PsA outcome measurement.

